Most Recent Articles about ACAD
https://www.zacks.com/stock/news/2240974/biotech-stock-roundup-amlx-acad-down-on-study-data-mrna-rgls-gain-on-updates-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2240974
Mar 14, 2024 - Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.
zc:7324680728588329649
0
https://www.zacks.com/stock/news/2212223/sana-bio-sana-stock-rallies-105-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212223
Jan 18, 2024 - Sana Bio (SANA) rallies 105% after the company reports encouraging pipeline progress with its candidates, SC291 and SC262, for oncology and autoimmune indications.
zc:3647089549820354034
0
https://www.zacks.com/stock/news/2210929/what-s-in-store-for-thermo-fisher-tmo-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2210929
Jan 16, 2024 - Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and the latest strategic pacts.
zc:-2354810804236870659
0